Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study

Clinical Research in Cardiology

Volumn 107, Issue 2, 2018, Pages 95-107

  Morbach, Caroline ^a   Buck, Thomas ^b,c   Rost, Christian ^a,d   Peter, Sebastian ^a,e   Günther, Stephan ^a,f   Störk, Stefan ^a   Prettin, Christiane ^g   Erbel, Raimund ^b   Ertl, Georg ^a   Angermann, Christiane E ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Klinikum Westfalen   (Germany)

^d Cardiological Practice   (Germany)

^e Kitzinger Land Hospital   (Germany)

^f Barmherzige Brüder Hospital   (Germany)

^g UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

B type natriuretic peptide; Diagnosis; Heart failure; Portable echocardiography; Primary care; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ADULT; ARTICLE; CLINICAL ASSESSMENT; COLOR DOPPLER ECHOCARDIOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART VENTRICLE HYPERTROPHY; HUMAN; IMMUNOFLUORESCENCE TEST; MALE; MIDDLE AGED; POINT OF CARE SYSTEM; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TRAINING; BLOOD; CARDIOLOGIST; CLINICAL COMPETENCE; CLINICAL PROTOCOL; CLINICAL TRIAL; DEVICES; DIAGNOSTIC IMAGING; EDUCATION; FEASIBILITY STUDY; GENERAL PRACTITIONER; GERMANY; IN SERVICE TRAINING; MEDICAL EDUCATION; METHODOLOGY; MULTICENTER STUDY; OBSERVER VARIATION; PATHOPHYSIOLOGY; POINT OF CARE TESTING; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PROGNOSIS; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK FACTOR; TIME FACTOR;

BIOMARKERS; CARDIOLOGISTS; CLINICAL COMPETENCE; CLINICAL PROTOCOLS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; EDUCATION, MEDICAL, CONTINUING; FEASIBILITY STUDIES; GENERAL PRACTITIONERS; GERMANY; HEART FAILURE; HUMANS; INSERVICE TRAINING; NATRIURETIC PEPTIDE, BRAIN; OBSERVER VARIATION; POINT-OF-CARE SYSTEMS; POINT-OF-CARE TESTING; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RISK FACTORS; TIME FACTORS;

EID: 85034089723     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-017-1181-3     Document Type: Article

References (75)

1. Kannel WB (2000) Incidence and epidemiology of heart failure. Heart Fail Rev 5:167–173
2. Mosterd A, Hoes AW (2007) Clinical epidemiology of heart failure. Heart 93:1137–1146
3. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH (2004) Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 25:1614–1619
4. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P (2017) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135:e146–e603
5. Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK (2002) Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 23:1867–1876
6. Hobbs FD, Korewicki J, Cleland JG, Eastaugh J, Freemantle N, Investigators I (2005) The diagnosis of heart failure in European primary care: the IMPROVEMENT programme survey of perception and practice. Eur J Heart Fail 7:768–779
7. Fuat A, Hungin AP, Murphy JJ (2003) Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 326:196
8. Stork S, Handrock R, Jacob J, Walker J, Calado F, Lahoz R, Hupfer S, Klebs S (2017) Treatment of chronic heart failure in Germany: a retrospective database study. Clin Res Cardiol 106:923–932
9. Boonman-de Winter LJ, Rutten FH, Cramer MJ, Landman MJ, Liem AH, Rutten GE, Hoes AW (2012) High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia 55:2154–2162
10. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW (2005) Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26:1887–1894
11. Remes J, Miettinen H, Reunanen A, Pyorala K (1991) Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 12:315–321
12. Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, Walsh HJ, Gordon G, Bagg W, Oxenham H, Yandle T, Richards M, Sharpe N (2003) Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol 42:1793–1800
13. McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446
14. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Sutton GC (1997) Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350:1349–1353
15. Clarke KW, Gray D, Hampton JR (1994) Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 71:584–587
16. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200
17. Wierzchowiecki M, Poprawski K, Nowicka A, Kandziora M, Piatkowska A (2005) Knowledge of primary care physicians, cardiologists from cardiology clinics, internal and cardiology department physicians about chronic heart failure diagnosis and treatment. Pol Merkur Lekarski 18:210–215
18. Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293–302
19. Yusuf S, Pitt B, Davis CE, Hood WB Jr, Cohn JN (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685–691
20. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669–677
21. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847
22. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442
23. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Breathing Not Properly Multinational Study I (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167
24. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP (2004) Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350:647–654
25. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS (2002) B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from breathing not properly (BNP) Multinational Study. Circulation 106:416–422
26. Burri E, Hochholzer K, Arenja N, Martin-Braschler H, Kaestner L, Gekeler H, Hatziisaak T, Buttiker M, Fraulin A, Potocki M, Breidthardt T, Reichlin T, Socrates T, Twerenbold R, Mueller C (2012) B-type natriuretic peptide in the evaluation and management of dyspnoea in primary care. J Intern Med 272:504–513
27. Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, Hardman SM, Dargie HJ, Cowie MR (2005) The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail 7:537–541
28. Mogelvang R, Goetze JP, Schnohr P, Lange P, Sogaard P, Rehfeld JF, Jensen JS (2007) Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide. J Am Coll Cardiol 50:1694–1701
29. Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, Johnston JI, Smellie WS, Duffy V, Cawley P (2006) The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract 56:327–333
30. Collinson PO (2006) The cost effectiveness of B-Type natriuretic peptide measurement in the primary care setting-a UK perspective. Congest Heart Fail 12:103–107
31. Sim V, Hampton D, Phillips C, Lo SN, Vasishta S, Davies J, Penney M (2003) The use of brain natriuretic peptide as a screening test for left ventricular systolic dysfunction-cost-effectiveness in relation to open access echocardiography. Fam Pract 20:570–574
32. Barrios V, Llisterri JL, Escobar C, Alfaro P, Colado F, Ridocci F, Matali A (2011) Clinical applicability of B-type natriuretic peptide in patients with suspected heart failure in primary care in Spain: the PANAMA study. Expert Rev Cardiovasc Ther 9:579–585
33. Taylor CJ, Roalfe AK, Iles R, Hobbs FR, investigators R, Barton P, Deeks J, McCahon D, Cowie MR, Sutton G, Davis RC, Mant J, McDonagh T, Tait L (2017) Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study. Br J Gen Pract 67:e94-e102
34. Kelder JC, Cramer MJ, van Wijngaarden J, van Tooren R, Mosterd A, Moons KG, Lammers JW, Cowie MR, Grobbee DE, Hoes AW (2011) The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation 124:2865–2873
35. Lang NN, Wong CM, Dalzell JR, Jansz S, Leslie SJ, Gardner RS (2014) The ease of use and reproducibility of the alere heart check system: a comparison of patient and healthcare professional measurement of BNP. Biomark Med 8:791–796
36. Monfort A, Da Silva K, Vodovar N, Gayat E, Cohen-Solal A, Manivet P (2015) Clinical evaluation of the heart check system, a new quantitative measurement of fresh capillary BNP. Biomark Med 9:1323–1330
37. Olausson J, Peterson C, Bergstrom M, Larsson A (2015) Evaluation of the meritas(R) BNP test for point-of-care testing. Clin Lab 61:727–730
38. Di Somma S, Zampini G, Vetrone F, Soto-Ruiz KM, Magrini L, Cardelli P, Ronco C, Maisel A, Peacock FW (2014) Opinion paper on utility of point-of-care biomarkers in the emergency department pathways decision making. Clin Chem Lab Med 52:1401–1407
39. Iwaz JA, Maisel AS (2016) Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management. Expert Rev Mol Diagn 16:641–650
40. Pecoraro V, Banfi G, Germagnoli L, Trenti T (2017) A systematic evaluation of immunoassay point-of care-testing to define impact on patients outcomes. Ann Clin Biochem 54:420–431
41. Cals JW, Schols AM, van Weert HC, Stevens F, Zeijen CG, Holtman G, Lucassen WA, Berger MY (2014) Point-of-care testing in family practices: present use and need for tests in the future. Ned Tijdschr Geneeskd 158:A8210
42. Tait L, Roalfe AK, Mant J, Cowie MR, Deeks JJ, Iles R, Barton PM, Taylor CJ, Derit M, Hobbs FD (2012) The REFER (REFer for EchocaRdiogram) protocol: a prospective validation of a clinical decision rule, NT-proBNP, or their combination, in the diagnosis of heart failure in primary care. Rationale and design. BMC Cardiovasc Disord 12:97
43. Madamanchi C, Alhosaini H, Sumida A, Runge MS (2014) Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. Int J Cardiol 176:611–617
44. Maisel A, Mueller C, Adams K Jr, Anker SD, Aspromonte N, Cleland JG, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazaa A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhyden M, Yancy CW, Zannad F, Braunwald E (2008) State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 10:824–839
45. Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, Luchner A, McDonagh T, Mair J, Nieminen M, Francis G (2003) Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24:1710–1718
46. Smith H, Pickering RM, Struthers A, Simpson I, Mant D (2000) Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ 320:906–908
47. Excellence NIoHaC Chronic heart failure in adults: management. CG108. https://www.nice.org.uk/guidance/cg108/chapter/1-Guidance-diagnosing-heart-failure. Accessed 29 Sept 2017
48. Seraphim A, Paschou SA, Grapsa J, Nihoyannopoulos P (2016) Pocket-sized echocardiography devices: one stop shop service? J Cardiovasc Ultrasound 24:1–6
49. Prinz C, Voigt JU (2011) Diagnostic accuracy of a hand-held ultrasound scanner in routine patients referred for echocardiography. J Am Soc Echocardiogr 24:111–116
50. Stoica R, Heller EN, Bella JN (2011) Point-of-care screening for left ventricular hypertrophy and concentric geometry using hand-held cardiac ultrasound in hypertensive patients. Am J Cardiovasc Dis 1:119–125
51. Fukuda S, Shimada K, Kawasaki T, Fujimoto H, Maeda K, Inanami H, Yoshida K, Jissho S, Taguchi H, Yoshiyama M, Yoshikawa J (2009) Pocket-sized transthoracic echocardiography device for the measurement of cardiac chamber size and function. Circ J 73:1092–1096
52. Kono Y, Fukuda S, Shimada K, Oe H, Maeda K, Kawasaki T, Fujimoto H, Otsuka K, Kubo T, Jissho S, Taguchi H, Yoshiyama M, Ito H, Yoshikawa J (2011) Pocket-sized echo for evaluation of mitral and tricuspid regurgitation. JACC Cardiovasc Imaging 4:921
53. Bornemann P, Johnson J, Tiglao S, Moghul A, Swain S, Bornemann G, Lustik M (2015) Assessment of primary care physicians’ use of a pocket ultrasound device to measure left ventricular mass in patients with hypertension. J Am Board Fam Med 28:706–712
54. Spencer KT, Anderson AS, Bhargava A, Bales AC, Sorrentino M, Furlong K, Lang RM (2001) Physician-performed point-of-care echocardiography using a laptop platform compared with physical examination in the cardiovascular patient. J Am Coll Cardiol 37:2013–2018
55. Fedson S, Neithardt G, Thomas P, Lickerman A, Radzienda M, DeCara JM, Lang RM, Spencer KT (2003) Unsuspected clinically important findings detected with a small portable ultrasound device in patients admitted to a general medicine service. J Am Soc Echocardiogr 16:901–905
56. Lipczynska M, Szymanski P, Klisiewicz A, Hoffman P (2011) Hand-carried echocardiography in heart failure and heart failure risk population: a community based prospective study. J Am Soc Echocardiogr 24:125–131
57. Evangelista A, Galuppo V, Mendez J, Evangelista L, Arpal L, Rubio C, Vergara M, Liceran M, Lopez F, Sales C, Miralles V, Galinsoga A, Perez J, Arteaga M, Salvador B, Lopez C, Garcia-Dorado D (2016) Hand-held cardiac ultrasound screening performed by family doctors with remote expert support interpretation. Heart 102:376–382
58. Filipiak-Strzecka D, John B, Kasprzak JD, Michalski B, Lipiec P (2013) Pocket-size echocardiograph–a valuable tool for nonexperts or just a portable device for echocardiographers? Adv Med Sci 58:67–72
59. Sicari R, Galderisi M, Voigt JU, Habib G, Zamorano JL, Lancellotti P, Badano LP (2011) The use of pocket-size imaging devices: a position statement of the European Association of Echocardiography. Eur J Echocardiogr 12:85–87
60. Seward JB, Douglas PS, Erbel R, Kerber RE, Kronzon I, Rakowski H, Sahn LD, Sisk EJ, Tajik AJ, Wann S (2002) Hand-carried cardiac ultrasound (HCU) device: recommendations regarding new technology. A report from the Echocardiography Task Force on New Technology of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15:369–373
61. Yates J, Royse CF, Royse C, Royse AG, Canty DJ (2016) Focused cardiac ultrasound is feasible in the general practice setting and alters diagnosis and management of cardiac disease. Echo Res Pract 3:63–69
62. Mehrhof F, Loffler M, Gelbrich G, Ozcelik C, Posch M, Hense HW, Keil U, Scheffold T, Schunkert H, Angermann C, Ertl G, Jahns R, Pieske B, Wachter R, Edelmann F, Wollert KC, Maisch B, Pankuweit S, Erbel R, Neumann T, Herzog W, Katus H, Muller-Tasch T, Zugck C, Dungen HD, Regitz-Zagrosek V, Lehmkuhl E, Stork S, Siebert U, Wasem J, Neumann A, Gohler A, Anker SD, Kohler F, Mockel M, Osterziel KJ, Dietz R, Rauchhaus M, Competence Network Heart F (2010) A network against failing hearts—introducing the German “Competence Network Heart Failure”. Int J Cardiol 145:135–138
63. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, Clopton P, Maisel A (2001) A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37:386–391
64. Kannel WB, D’Agostino RB, Silbershatz H, Belanger AJ, Wilson PW, Levy D (1999) Profile for estimating risk of heart failure. Arch Intern Med 159:1197–1204
65. Schocken DD, Arrieta MI, Leaverton PE, Ross EA (1992) Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 20:301–306
66. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD (1993) Echocardiography in chronic heart failure in the community. Q J Med 86:17–23
67. Hlatky MA, Fleg JL, Hinton PC, Lakatta EG, Marcus FI, Smith TW, Strauss HC (1986) Physician practice in the management of congestive heart failure. J Am Coll Cardiol 8:966–970
68. Ware JE (1996) The SF-36 health survey. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials. Raven, Philadelphia, pp 337–346
69. Lowe B, Grafe K, Zipfel S, Witte S, Loerch B, Herzog W (2004) Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire. Psychother Psychosom 73:386–390
70. Kroenke K, Spitzer RL, Williams JB (2003) The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 41:1284–1292
71. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J (2004) Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 140:189–202
72. Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM (2006) Evidence of bias and variation in diagnostic accuracy studies. CMAJ 174:469–476
73. Roberts E, Ludman AJ, Dworzynski K, Al-Mohammad A, Cowie MR, McMurray JJ, Mant J, Nice Guideline Development Group for Acute Heart Failure (2015) The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ 350:h910
74. Kelder JC, Cramer MJ, Verweij WM, Grobbee DE, Hoes AW (2011) Clinical utility of three B-type natriuretic peptide assays for the initial diagnostic assessment of new slow-onset heart failure. J Card Fail 17:729–734
75. Papanicolas I, Jha AK (2017) Challenges in international comparison of health care systems. JAMA 318:515–516